Chinese pharma orders freeze dryers

Chinese API maker Zheiiang Hisun Pharmaceutical Co. has placed a $21 million order for freeze dryers with automatic load and unload systems. The order, for seven freeze dryers, signals Hisun expansion into formulated pharmaceutical products for injection in the areas of oncology and infective diseases, says freezer maker GEA Lyophil.

Hisun is said to be planning a $143-million investment in facilities in Fuyang, where the freeze dryers will be used, making it one of the biggest pharmaceutical production sites in China. The drug maker's products include anti-infection, anti-parasite, endocrine regulation, immunosuppressant and antidepressant drugs. The company exports more than 80% of its products and has a presence in 30 countries in the Far East, Europe and the U.S.

Another GEA Group unit--GEA Pharma Systems--earlier unveiled an inline blender for use between its continuous granulation/drying system and a tablet press, combining two production steps.

- here's the freeze dryer announcement

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.